Podcast: How to manage life after cancer treatment
Michael Roth, M.D.
Department of Pediatrics, Division of Pediatrics
About Dr. Michael Roth
Dr. Michael Roth graduated from New York University School of Medicine and completed a Pediatrics residency and Pediatric Hematology/Oncology fellowship at the Albert Einstein College of Medicine. He is currently a professor of pediatrics at The University of Texas MD Anderson Cancer Center. Dr. Roth specializes in caring for children and adolescents with leukemia and lymphoma and he is the Director of the Childhood Cancer Survivorship Program. Dr. Roth’s clinical research focuses on improving outcomes for adolescents and young adults (AYA) with cancer and he is the chair of the Children’s Oncology Group AYA Oncology Discipline Committee. In addition, Dr. Roth is the co-director of the AYA Program and the director of the Survivorship program at The University of Texas MD Anderson Cancer Center.
Present Title & Affiliation
Primary Appointment
Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Medical Director, Survivorship Program, Division of Cancer Survivorship, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Childhood Cancer Survivorship Programs, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2006 | New York University School of Medicine, New York, NY, USA, MD, Medicine |
| 2002 | Brandeis University, Waltham, MA, USA, BA, Biology |
Postgraduate Training
| 2010-2012 | Research Fellowship, Laboratory of Cell Biology, Albert Einstein College of Medicine, Bronx, NY |
| 2009-2012 | Clinical Fellowship, Pediatrics Hematology/Oncology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY |
| 2006-2009 | Intern & Resident, Pediatrics, Albert Einstein College of Medicine, Bronx, NY |
Board Certifications
| 2013 | American Board of Pediatrics, Pediatric Hematology-Oncology |
| 2009 | American Board of Pediatrics, General Pediatrics |
Honors & Awards
| 2020 | Texas Super Doctors, Texas Monthly |
| 2018 | Faculty Excellence in Prevention Outreach, MD Anderson Cancer Center |
| 2017 | New York Super Doctors- Best Doctors |
| 2014 | Henry L. Moses Award in Basic Science, Montefiore Medical Center |
| 2013 | Lewis Fraad Award for Excellence in the Teaching of Residents, Children’s Hospital at Montefiore |
| 2013 | New York Super Doctors Rising Stars |
| 2013 | Society for Pediatric Research Inductee |
| 2011 | Leo M. Davidoff Society Inductee for Outstanding Achievement in Medical Student Education |
| 2007 | Best Resident Educator Award, Children’s Hospital at Montefiore |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Berkman AM, Robert RS, Roth M, Askins MA. A review of psychological symptoms and post-traumatic growth among adolescent and young adult survivors of childhood cancer. J Health Psychol 27(4):1359105320971706, 2022. e-Pub 2020. PMID: 33153307.
- Makhnoon S, Corredor J, Arun B, Bell D, Yarbrough A, Livingston JA, Peterson SK, Roth M. Impact of a Genetic Evaluation Initiative to Increase Access to Genetic Services for Adolescent and Young Adults at a Tertiary Cancer Hospital. J Adolesc Young Adult Oncol 10(3):296-302, 2021. e-Pub 2020. PMID: 32830989.
- Cuglievan B, Berkman A, Dibaj S, Wang J, Andersen CR, Livingston JA, Gill J, Bleyer A, Roth M. Impact of Lagtime, Health Insurance Type, and Income Status at Diagnosis on the Long-Term Survival of Adolescent and Young Adult Cancer Patients. J Adolesc Young Adult Oncol 10(2):164-174, 2021. e-Pub 2020. PMID: 32678703.
- Dickens DS, Roth ME, Pollock BH, Langevin AM. Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs. JCO Oncol Pract 16(10):JOP1900707, 2020. e-Pub 2020. PMID: 32396490.
- Roth M, Mittal N, Saha A, Freyer DR. The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment. J Adolesc Young Adult Oncol 9(4):522-527, 2020. e-Pub 2020. PMID: 32077782.
- Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka D, DePombo A, Lee HJ, de Groot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020. PMID: 32484922.
- Harrison DJ, Gill JD, Roth ME, Zhang W, Teicher B, Erickson S, Gatto G, Kurmasheva RT, Houghton PJ, Smith MA, Kolb EA, Gorlick R. Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium. Pediatr Blood Cancer 67(6):e28222, 2020. e-Pub 2020. PMID: 32207565.
- Siembida EJ, Loomans-Kropp HA, Trivedi N, O'Mara A, Sung L, Tami-Maury I, Freyer DR, Roth M. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention. Cancer 126(5):949-957, 2020. e-Pub 2019. PMID: 31869454.
- Roth ME, Unger JM, O'Mara AM, Lewis MA, Budd T, Johnson RH, Pollock BH, Blanke C, Freyer DR. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era. Cancer Med 9(6):2146-2152, 2020. e-Pub 2020. PMID: 32009305.
- Roth L, Moerdler S, Weiser D, Douglas L, Gill J, Roth M. Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses. Int J Pediatr Otorhinolaryngol 121:34-40, 2019. e-Pub 2019. PMID: 30861425.
- Gilchrist SC, Roth M, Livingston JA, Hildebrandt MAT, Kleinerman ES, Banchs J. Short-Term Changes in Cardiac Function in Osteosarcoma Patients Receiving Anthracyclines. J Adolesc Young Adult Oncol 8(3):385-386, 2019. e-Pub 2019. PMID: 30794081.
- Currier AW, Kolb EA, Gorlick RG, Roth ME, Gopalakrishnan V, Sampson VB. p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma. Sci Rep 9(1):6161, 2019. e-Pub 2019. PMID: 30992462.
- Moerdler S, Zhang L, Gerasimov E, Zhu C, Wolinsky T, Roth M, Goodman N, Weiser DA. Physician perspectives on compassionate use in pediatric oncology. Pediatr Blood Cancer 66(3):e27545, 2019. e-Pub 2018. PMID: 30408307.
- Andolina JR, Burke MJ, Hijiya N, Chaudhury S, Schultz KR, Roth ME. Practice Patterns of Physician Treatment for Pediatric Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant 25(2):321-327, 2019. e-Pub 2018. PMID: 30267760.
- Zhu C, Olson KA, Roth M, Geller DS, Gorlick RG, Gill J, Laack NN, Randall RL. Provider views on the management of Ewing sarcoma of the spine and pelvis. J Surg Oncol 117(3):417-424, 2018. e-Pub 2017. PMID: 29044582.
- Shaul E, Roth M, Lo Y, Geller DS, Hoang B, Yang R, Malkin D, Gorlick R, Gill J. Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma. Cancer 124(6):1242-1250, 2018. e-Pub 2018. PMID: 29313943.
- Bailey K, Roth M, Weiser D, Gill J. High-Dose Chemotherapy with Stem Cell Rescue in Desmoplastic Small Round Cell Tumor: A Single-Institution Experience and Review of the Literature. Sarcoma 2018:1948093, 2018. e-Pub 2018. PMID: 29853779.
- Maxwell RR, Egan-Sherry D, Gill JB, Roth ME. Management of Chemotherapy-Induced Febrile Neutropenia in Pediatric Oncology Patients: A North American Survey of Pediatric Hematology/Oncology and Pediatric Infectious Disease Physicians. Pediatr Blood Cancer 64(12), 2017. e-Pub 2017. PMID: 28748605.
- Peterson HM, Hoang BH, Geller D, Yang R, Gorlick R, Berger J, Tingling J, Roth M, Gill J, Roblyer D. In vivo, noninvasive functional measurements of bone sarcoma using diffuse optical spectroscopic imaging. J Biomed Opt 22(12):1-9, 2017. PMID: 29264893.
- Ren T, Piperdi S, Koirala P, Park A, Zhang W, Ivenitsky D, Zhang Y, Villanueva-Siles E, Hawkins DS, Roth M, Gorlick R. CD49b inhibits osteogenic differentiation and plays an important role in osteosarcoma progression. Oncotarget 8(50):87848-87859, 2017. e-Pub 2017. PMID: 29152125.
- Morris J, Yang R, Roth M, Gill J, Gorlick R, Lo Y, Hoang BH, Garfein E, Geller DS. Mechanical analysis of the vascularized fibular graft prosthetic composite (VFGPC) for internal hemipelvectomy reconstruction. J Surg Oncol 115(7):864-869, 2017. e-Pub 2017. PMID: 28543392.
- Gill J, Connolly P, Roth M, Chung SH, Zhang W, Piperdi S, Hoang B, Yang R, Guzik H, Morris J, Gorlick R, Geller DS. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis. PLoS One 12(3):e0173322, 2017. e-Pub 2017. PMID: 28264040.
- Yang Y, Yang R, Roth M, Piperdi S, Zhang W, Dorfman H, Rao P, Park A, Tripathi S, Freeman C, Zhang Y, Sowers R, Rosenblum J, Geller D, Hoang B, Gill J, Gorlick R. Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model. Genes Cancer 8(1-2):484-494, 2017. PMID: 28435520.
- Cohen B, Roth M, Marron JM, Gray SW, Geller DS, Hoang B, Gorlick R, Janeway KA, Gill J. Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling. Ann Surg Oncol 23(Suppl 5):990-997, 2016. e-Pub 2016. PMID: 27459981.
- Geller DS, Morris J, Revskaya E, Kahn M, Zhang W, Piperdi S, Park A, Koirala P, Guzik H, Hall C, Hoang B, Yang R, Roth M, Gill J, Gorlick R, Dadachova E. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R). Nucl Med Biol 43(12):812-817, 2016. e-Pub 2016. PMID: 27744117.
- Weintraub L, Figueiredo L, Roth M, Levy A. The feasibility of implementing a communication skills training course in pediatric hematology/oncology fellowship. Pediatr Hematol Oncol 33(7-8):480-490, 2016. e-Pub 2016. PMID: 27922758.
- Koirala P, Roth ME, Gill J, Chinai JM, Ewart MR, Piperdi S, Geller DS, Hoang BH, Fatakhova YV, Ghorpade M, Zang X, Gorlick R. HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival. Sci Rep 6:31154, 2016. e-Pub 2016. PMID: 27531281.
- Koirala P, Roth ME, Gill J, Piperdi S, Chinai JM, Geller DS, Hoang BH, Park A, Fremed MA, Zang X, Gorlick R. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep 6:30093, 2016. e-Pub 2016. PMID: 27456063.
- Polishchuk V, Khazal S, Berulava G, Roth M, Mahadeo KM. 5-Azacitidine Monotherapy Followed by Related Haploidentical Hematopoietic Stem Cell Transplantation Achieves Durable Remission in a Pediatric Patient With Acute Undifferentiated Leukemia Refractory to High-Dose Chemotherapy. Pediatr Blood Cancer 63(6):1111-2, 2016. e-Pub 2016. PMID: 26914221.
- Roth ME, O'Mara AM, Seibel NL, Dickens DS, Langevin AM, Pollock BH, Freyer DR. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program. J Oncol Pract 12(4):e388-95, 2016. e-Pub 2016. PMID: 27026648.
- Roth M, Barris DM, Piperdi S, Kuo V, Everts S, Geller D, Houghton P, Kolb EA, Hawthorne T, Gill J, Gorlick R. Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma. Pediatr Blood Cancer 63(1):32-8, 2016. e-Pub 2015. PMID: 26305408.
Patient Reviews
CV information above last modified October 11, 2024